217 related articles for article (PubMed ID: 7795143)
21. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
Osooli M; Steen Carlsson K; Astermark J; Berntorp E
Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
[TBL] [Abstract][Full Text] [Related]
22. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B
Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763
[TBL] [Abstract][Full Text] [Related]
23. A global view on prophylaxis: possibilities and consequences.
Shapiro AD
Haemophilia; 2003 May; 9 Suppl 1():10-7; discussion 18. PubMed ID: 12709032
[TBL] [Abstract][Full Text] [Related]
24. Primary prophylaxis in children with haemophilia.
Coppola A; Di Capua M; De Simone C
Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s4-11. PubMed ID: 19105503
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.
Fischer K; Astermark J; van der Bom JG; Ljung R; Berntorp E; Grobbee DE; van den Berg HM
Haemophilia; 2002 Nov; 8(6):753-60. PubMed ID: 12410643
[TBL] [Abstract][Full Text] [Related]
26. Update on treatment regimens: prophylaxis versus on-demand therapy.
Manco-Johnson MJ
Semin Hematol; 2003 Jul; 40(3 Suppl 3):3-9. PubMed ID: 14690062
[TBL] [Abstract][Full Text] [Related]
27. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
[TBL] [Abstract][Full Text] [Related]
28. Haemophilia treatment in the United Kingdom from 1969 to 1974.
Biggs R
Br J Haematol; 1977 Apr; 35(4):487-504. PubMed ID: 871406
[TBL] [Abstract][Full Text] [Related]
29. Haemophilia care in Europe: the ESCHQoL study.
Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
[TBL] [Abstract][Full Text] [Related]
30. Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s.
Fischer K; Steen Carlsson K; Petrini P; Holmström M; Ljung R; van den Berg HM; Berntorp E
Blood; 2013 Aug; 122(7):1129-36. PubMed ID: 23777770
[TBL] [Abstract][Full Text] [Related]
31. Haemophilia prophylaxis in young patients--a long-term follow-up.
Löfqvist T; Nilsson IM; Berntorp E; Pettersson H
J Intern Med; 1997 May; 241(5):395-400. PubMed ID: 9183307
[TBL] [Abstract][Full Text] [Related]
32. Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis.
Olivieri M; Kurnik K; Pfluger T; Bidlingmaier C
Haemophilia; 2012 May; 18(3):369-74. PubMed ID: 22032268
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis in children with haemophilia - the Polish experience.
Klukowska A; Urasinski T; Janik-Moszant A; Bobrowska H; Balwierz W; Woznica-Karczmarz I; Dobaczewski G; Wlazlowski M; Koltan A; Badowska W; Dakowicz L; Karolczyk G; Kostrzewska M; Korczowski B; Wasinski D; Pietrys D; Laguna P; Wysocka M
Haemophilia; 2014 Jan; 20(1):e108-10. PubMed ID: 24251651
[No Abstract] [Full Text] [Related]
34. Will recent innovations in therapy save perceived deficiencies in self-sufficiency policies.
Limentani SA
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S81-4. PubMed ID: 7795145
[TBL] [Abstract][Full Text] [Related]
35. Aspects of haemophilia prophylaxis in Sweden.
Ljung RC
Haemophilia; 2002 Mar; 8 Suppl 2():34-7. PubMed ID: 11966851
[TBL] [Abstract][Full Text] [Related]
36. Is on-demand treatment effective in patients with severe haemophilia?
Aznar JA; Marco A; Jiménez-Yuste V; Fernández-Fontecha E; Pérez R; Soto I; Parra R; Moreno M; Mingot ME; Moret A;
Haemophilia; 2012 Sep; 18(5):738-42. PubMed ID: 22537601
[TBL] [Abstract][Full Text] [Related]
37. The current status of prophylactic replacement therapy in children and adults with haemophilia.
Ljung R; Gretenkort Andersson N
Br J Haematol; 2015 Jun; 169(6):777-86. PubMed ID: 25819695
[TBL] [Abstract][Full Text] [Related]
38. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
Steen Carlsson K; Höjgård S; Glomstein A; Lethagen S; Schulman S; Tengborn L; Lindgren A; Berntorp E; Lindgren B
Haemophilia; 2003 Sep; 9(5):555-66. PubMed ID: 14511294
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.
Levine PH
N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642
[No Abstract] [Full Text] [Related]
40. [Possibilities of self-treatment in hemophilias. Preliminary report].
Göbel U; Schulz RD
Dtsch Med Wochenschr; 1972 Sep; 97(37):1376-9. PubMed ID: 5055724
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]